💨 Abstract

Scientists at King's College London are exploring a new form of immunotherapy for certain types of cancer, such as breast and ovarian cancers that express HER2. They are using a different antibody type, IgE, which activates the immune system in a unique way, stimulating otherwise inactive immune cells in the tumor's microenvironment.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖